LIFE Study: Least Invasive Fast-Track EVAR

Inclusion Criteria: * Patient is ≥ 18 years of age. * Patients who are male or non-pregnant female (females of child bearing potential must have a negative pregnancy test prior to enrollment into the study). * Patient has signed an IRB approved informed consent form. * Patient is considered by the treating physician to be a candidate for elective open surgical repair of the AAA. * Patient has an infrarenal abdominal aortic aneurysm that meets at least one of the following: abdominal aortic aneurysm \>5.0 cm in diameter, aneurysm has increased in size by 0.5 cm in last 6 months, or maximum diameter of aneurysm exceeds 1.5 times the transverse dimension of an adjacent non-aneurysm exceeds 1.5 times the transverse dimension of an adjacent non-aneurysmal aortic segment. * Patient has suitable anatomy that allows use of the TriVascular Ovation® Abdominal Stent Graft Platform. * Patient has suitable femoral arteries at the percutaneous access site that allow use of the Perclose ProGlide Suture-Mediated Closure System via the pre-close technique. * Patient must be willing to comply with all required follow-up exams. Exclusion Criteria: * Patient has a need for emergent surgery. * Patient has a dissecting aneurysm. * Patient has an acutely ruptured aneurysm. * Patient has an acute vascular injury. * Patient has had a previous repair of the abdominal aortic aneurysm or the iliac artery. * Patient has a mycotic aneurysm or has an active systemic infection. * Patient has unstable angina. * Patient has unstable peripheral artery disease with critical limb ischemia. * Patient has congestive heart failure. * Patient has had a myocardial infarction and/or stroke within the past 3 months. * Patient requires use of techniques that would cover the renal arteries. * Patient requires planned adjunctive devices to complete the procedure. * Patient has a major surgical or interventional procedure planned during or within ±30 days of the AAA repair. * Patient has history of connective tissue disease. * Patient has history of bleeding disorders or refuses blood transfusions. * Patient has dialysis dependent renal failure or baseline serum creatinine level \>2.0mg/dl. * Patient has a known hypersensitivity or contraindication to anticoagulation or contrast media that is not amenable to pre-treatment. * Patient has a known allergy or intolerance to polytetrafluoroethylene (PTFE), PEG-based polymers, fluorinated ethylene propylene (FEP) or nitinol. * Patient is on home oxygen. * Patient is morbidly obese (BMI ≥40 kg/m2). * Patient was admitted from a skilled nursing facility. * Patient has a limited life expectancy of less than 1 year. * Patient has an inability to be discharged within 1 day of the procedure. * Patient is currently participating in an investigational device or drug clinical trial. * Patient has other medical, social or psychological conditions that, in the opinion of the investigator, preclude them from receiving the pre-treatment, required treatment, and post-treatment procedures and evaluations.